![August 2024 Labs in Court](https://www.g2intelligence.com/wp-content/uploads/2024/07/Aug24.LIA_.LabsinCourt.KL-JH-iStock-1100x800-1-1080x675.jpg)
August 2024 Labs in Court
COVID-19-related schemes dominated recent enforcement efforts, which include a national healthcare fraud enforcement action
COVID-19-related schemes dominated recent enforcement efforts, which include a national healthcare fraud enforcement action
The choice of venue was likely inspired by the longstanding anti-regulatory stance of the state's federal judges.
Genetic testing related fraud was a theme in recent enforcement actions involving medical laboratories and lab testing
Laboratory diagnostics manufacturers receive regulatory scrutiny for issues including marketing, quality, and unapproved changes to tests
Recent enforcement actions and court cases include kickback schemes a-plenty and a reminder to focus on HIPAA compliance